Adjuvant treatment

HPB

Volumn 8, Issue 5, 2006, Pages 352-364

  Sultana, Asma ^a   Neoptolemos, John ^a   Ghaneh, Paula ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Adjuvant therapy; Pancreatic cancer; Randomised controlled trial

Indexed keywords

CISPLATIN; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; FLUOROPYRIMIDINE; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; MITOMYCIN C; MITOXANTRONE;

ARTERY THROMBOSIS; BILE DUCT OBSTRUCTION; BLOOD TOXICITY; BODY WEIGHT DISORDER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CHOLANGITIS; CLINICAL TRIAL; CONTINUOUS INFUSION; DIGESTIVE SYSTEM ULCER; DISEASE FREE SURVIVAL; DRUG EFFICACY; DRUG METABOLISM; EXOCRINE GLAND; EXTERNAL BEAM RADIOTHERAPY; FEBRILE NEUTROPENIA; FOLLOW UP; HUMAN; INFECTION; INTRAOPERATIVE RADIOTHERAPY; META ANALYSIS; OUTCOMES RESEARCH; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREAS RESECTION; PROGNOSIS; REVIEW; SUPERIOR MESENTERIC ARTERY; SURVIVAL RATE; SURVIVAL TIME; SYSTEMATIC REVIEW; VOMITING; WEIGHT REDUCTION;

EID: 33749173647     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1080/13651820600804146     Document Type: Review

References (63)

1. Parker, SI and Tong, T and Boldes, S and Wingo, PA. (1996) Cancer statistics, 1996 CA Cancer J Clin, 46, pp. 5-27.
2. Neoptolemos, J and Russell, RCG and Bramhall, SR and Theis, B. (1997) Low mortality following resection for pancreatic and periampullary tumours in 1026 patients Br J Surg, 84, pp. 1370-6.
3. Yeo, C and Abrams, R and Grochow, L and Sohn, TA and Ord, SE and Hruban, RH and (1997) Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival: A prospective, single-institution experience Ann Surg, 225, pp. 621-36.
4. Doughlass, H. (1995) Adjuvant therapy for pancreatic cancer World J Surg, 19, pp. 170-4.
5. Neoptolemos, J and Stocken, D and Dunn, J and Almond, J and Beger, HG and Pederzoli, P and (2001) Influence of resection margins on survival for patients with pancreatic cancer treated with adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomised controlled trial Ann Surg, 234, pp. 758-68.
6. Abrams, R and Lillemoe, K and Piantadosi, S. (2001) Continuing controversy over adjuvant therapy of pancreatic cancer Lancet, 358, pp. 1565.
7. Koshy, M and Landry, J and Cavanaugh, S and Fuller, CD and Willett, CG and Abrams, RA and (2005) A challenge to the therapeutic nihilism of ESPAC-1 Int J Radiat Oncol Biol Phys, 61, pp. 965-6.
8. Kalser, M and Ellenberg, S. (1985) Pancreatic cancer: Adjuvant combined radiation and chemotherapy following curative resection Arch Surg, 120, pp. 899-903.
9. Neoptolemos, J and Dunn, J and Stocken, D and Almond, J and Link, K and Beger, H and (2001) Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: A randomised controlled trial Lancet, 358, pp. 1576-85.
10. Neoptolemos, J and Stocken, D and Freiss, H and Bassi, C and Dunn, JA and Hickey, H and (2004) A randomised trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer N Engl J Med, 350, pp. 1200-10.
11. Bassi, C and Stocken, DD and Olah, A and Friess, H and Buckels, J and Hickey, H and (2005) Influence of surgical resection and post-operative complications on survival following adjuvant treatment for pancreatic cancer in the ESPAC-1 randomized controlled trial Dig Surg, 22, pp. 353-63.
12. Bakkevold, K and Arnesjo, B and Dahl, O and Kambestad, B. (1993) Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater - results of a controlled, prospective, randomised multicentre study Eur J Cancer, 29A, pp. 698-703.
13. Takada, T and Amano, H and Yasuda, H and Nimura, Y and Matsushiro, T and Kato, H and (2002) Is postoperative adjuvant chemotherapy useful for gall bladder carcinoma? A phase III multicentre prospective randomised controlled trial in patients with resected pancreaticobiliary carcinoma Cancer, 95, pp. 1685-95.
14. Stocken, D and Buchler, M and Dervenis, C and Bassi, C and Jeekel, H and Klinkenbijl, JH and (2005) Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer Br J Cancer, 92, pp. 1372-81.
15. NeuhausP, OettleH, PostS, GellertK, RidwelskiK, SchrammH, A randomised, prospective, multicentre, phase III trial of adjuvant chemotherapy with gemcitabine vs. observation in patients with resected pancreatic cancer ASCO, Orlando, 2005.
16. Kurosaki, I and Hatakeyama, K. (2004) The clinical efficacy of adjuvant systemic chemotherapy with gemcitabine in node-positive pancreatic cancer Hepatogastroenterology, 51, pp. 634-7.
17. Splinter, T and Obertop, H and Kok, T and Jeekel, J. (1989) Adjuvant chemotherapy after resection of adenocarcinoma of the periampullary region and head of pancreas. A non-randomised pilot study J Cancer Res Clin, 115, pp. 200-2.
18. Baumel, H and Huguier, M and Manderscheid, J and Fabre, JM and Houry, S and Fagot, H. (1994) Results of resection for cancer of exocrine pancreas: A study from the French Association of Surgery Br J Surg, 81, pp. 102-7.
19. Ishikawa, O and Ohigashi, H and Sasaki, Y and Furukawa, H and Kabuto, T and Kameyama, M and (1994) Liver perfusion chemotherapy via both the hepatic artery and portal vein to prevent hepatic metastasis after extended pancreatectomy for adenocarcinoma of the pancreas Am J Surg, 168, pp. 361-4.
20. Ishikawa, O and Ohigashi, H and Imaoka, S and Sasaki, Y and Kameyama, M and Nakamori, S and (1997) Regional chemotherapy to prevent hepatic metastases after resection of pancreatic cancer Hepatogastroenterology, 44, pp. 1541-6.
21. Ozaki, H and Kinoshita, T and Kosuge, T and Egawa, S and Kishi, K. (1990) Effectiveness of multimodality treatment for resectable pancreatic cancer Int J Pancreatol, 7, pp. 195-200.
22. Ozaki, H and Kinoshita, T and Kosuge, T and Shimada, K and Yamamoto, J and Tokuuye, K and (2000) Long-term survival after multimodality treatment for resectable pancreatic cancer Int J Pancreatol, 27, pp. 217-24.
23. Link, K and Formentini, A and Gansauge, F and Papachristov, E and Beger, HG and (1997) Regional coeliac artery infusion as adjuvant treatment after pancreatic cancer resection Digestion, 58, pp. 529-32.
24. Beger, H and Link, K and Gansauge, F. (1998) Adjuvant regional chemotherapy in advanced pancreatic cancer: Results of a prospective study Hepatogastroenterology, 45, pp. 638-43.
25. Papachristou, E and Link, K and Schoenberg, M. (2003) Regional coeliac artery infusion in the adjuvant treatment of pancreatic cancer Anticancer Res, 23, pp. 831-4.
26. Beger, H and Gansauge, F and Buchler, M and Link, K. (1999) Intraarterial adjuvant chemotherapy after pancreaticoduodenectomy for pancreatic cancer: Significant reduction in occurence of liver metastases World J Surg, 23, pp. 946-9.
27. Yamaue, H and Tani, M and Onishi, H and Kinoshita, H and Nakamori, M and Yokoyama, S and (2002) Locoregional chemotherapy for patients with pancreatic cancer. Intra-arterial adjuvant chemotherapy after pancreatectomy with portal vein resection Pancreas, 25, pp. 366-72.
28. Kayahara, M and Nagakawa, T and Ueno, K and Ohta, T and Takeda, T and Miyazaki, I. (1993) An evaluation of radical resection for pancreatic cancer based on the mode of recurrence as determined by autopsy and diagnostic imaging Cancer, 72, pp. 2118-23.
29. Yeo, C and Cameron, J and Sohn, T and Coleman, J and Sauter, PK and Hruban, RH and (1999) Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma Ann Surg, 229, pp. 613-24.
30. Leach, S and Lee, J and Charnsangavej, C and Cleary, KR and Lowy, AM and Fenoglio, CJ and (1998) Survival following pancreaticoduodenectomy with resection of the superior mesenteric-portal vein confluence for adenocarcinoma of the pancreatic head Br J Surg, 85, pp. 611-17.
31. Fossati, V and Cattaneo, G and Zerbi, A and Galli, L and Bordogna, G and Reni, M and (1995) The role of intraoperative therapy by electron beam and combination of adjuvant chemotherapy and external radiotherapy in carcinoma of the pancreas Tumori, 81, pp. 23-31.
32. Hiraoka, T and Uchino, R and Kanemitsu, K and Toyonaga, M and Saitoh, N and Nakamura, I and (1990) Combination of intraoperative radiation with resection of cancer of the pancreas Int J Pancreatol, 7, pp. 201-7.
33. Coquard, R and Ayzac, L and Gilly, F and Romestaing, P and Ardiet, JM and Sondaz, C and (1997) Intraoperative radiotherapy in resected pancreatic cancer: Feasibility and results Radiother Oncol, 44, pp. 271-5.
34. Zerbi, A and Fossati, V and Parolini, D. (1994) Intraoperative radiation therapy adjuvant to resection in the treatment of pancreatic cancer Cancer, 73, pp. 2930-5.
35. Tepper, J and Noyes, D and Krall, J and Sause, WT and Wolkov, HB and Dobelbower, RR and (1991) Intraoperative radiation therapy of pancreatic carcinoma. A report of RTOG 85-05 Int J Radiat Oncol Biol Phys, 21, pp. 1145-9.
36. Reni, M and Panucci, M and Ferreri, A and Balzano, G and Passoni, P and Cattaneo, GM and (2001) Effect of local control and survival of electron beam intraoperative irradiation for resectable pancreatic adenocarcinoma Int J Radiat Oncol Biol Phys, 50, pp. 651-8.
37. Sindelar, W and Kinsella, T. (1986) Randomised trial of intraoperative radiotherapy in resected carcinoma of the pancreas Int J Radiat Oncol Biol Phys, 12(Suppl 1), pp. 148.
38. Bosset, J and Pay, J and Gillet, M and Mantion, G and Pelissier, E and Schraub, S. (1992) Conventional external irradiation alone as an adjuvant treatment in resectable pancreatic cancer: Results of a prospective study Radiother Oncol, 24, pp. 191-4.
39. Klinkenbijl, J and Jeekel, J and Sahmoud, T and van Pel, R and Couvreur, ML and Veenhof, CH and (1999) Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region. Phase III trial of the EORTC Gastrointestinal Tract Cancer Cooperative Group Ann Surg, 230, pp. 776-84.
40. Koong, A and Mehta, V and Le, QT and Fisher, GA and Terris, DJ and Brown, JM and (2000) Pancreatic tumours show high levels of hypoxia Int J Radiat Oncol Biol Phys, 48, pp. 919-22.
41. Wayne, J and Abdalla, E and Wolff, R and Crane, CH and Pisters, PW and Evans, DB and (2002) Localised adenocarcinoma of the pancreas: The rationale of preoperative chemoradiation Oncologist, 7, pp. 34-45.
42. Hoffman, J and Lipsitz, S and Pisansky, T and Weese, JL and Solin, L and Benson, AB 3rd and (1998) Phase II trial of preoperative radiation therapy and chemotherapy for patients with localised, resectable adenocarcinoma of the pancreas: An Eastern Cooperative Oncology Group Study J Clin Oncol, 16, pp. 317-23.
43. Pendurthi, T and Hoffman, J and Ross, E and Johnson, DE and Eisenberg, BL. (1998) Preoperative versus postoperative chemoradiation for patients with resected pancreatic adenocarcinoma Am Surg, 64, pp. 686-92.
44. Spitz, F and Abbruzzese, J and Lee, J and Pisters, PW and Lowy, AM and Fenoglio, CJ and (1997) Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas J Clin Oncol, 15, pp. 928-37.
45. MorgantiA, TrodellaL, ValentiniV, DogliettoGB, ZiccarelliP, MacchiaG, Preoperative radiochemotherapy in pancreatic cancer: Preliminary resultsTumori 1999;85(1 Suppl 1):S27-S32 (in Italian).
46. Magnin, V and Moutardier, V and Giovannini, MH and Lelong, B and Giovannini, M and Viret, F and (2003) Neoadjuvant preoperative chemoradiation in patients with pancreatic cancer Int J Radiat Oncol Biol Phys, 55, pp. 1300-4.
47. Hopewell, J.(1983) Radiation effects on vascular tissue. In Cytotoxic insult to tissue: Effects on cell lineages. (pp. 228-57). Edinburgh: Churchill Livingstone.
48. Moutardier, V and Turrini, O and Huiart, L and Viret, F and Giovannini, MH and Magnin, V and (2004) A reappraisal of preoperative chemoradiation for localised pancreatic head ductal adenocarcinoma in a 5-year, single-institution experience J Gastrointest Surg, 8, pp. 502-10.
49. White, R and Hurwitz, H and Morse, M and Lee, C and Anscher, MS and Paulson, EK and (2001) Neoadjuvant chemoradiation for localised adenocarcinoma of the pancreas Ann Surg Oncol, 8, pp. 758-65.
50. Wolff, R. (2001) Neoadjuvant chemoradiation for localised adenocarcinoma of the pancreas: Great logic, grim reality Ann Surg Oncol, 810, pp. 747-8.
51. Breslin, T and Hess, K and Harbison, D and Jean, ME and Cleary, KR and Dackiw, AP and (2001) Neoadjuvant chemoradiation for adenocarcinoma of the pancreas: Treatment variables and survival duration Ann Surg Oncol, 8, pp. 123-32.
52. Pipas, JM and Barth, RJ and Zaki, B and Colacchio, TA and Gordon, SR and Sutton, JE and (2004) Docetaxel/gemcitabine followed by gemcitabine and radiotherapy in patients with pancreatic adenocarcinoma J Clin Oncol, 22(14S (July Suppl)), pp. 4109.
53. Nakamori, S and Tanaka, E and Marubashi, S and Miyamoto, A and Nagano, H and Dono, K and (2004) Neoadjuvant chemoradiation therapy with gemcitabine and accelerated hyperfractionated radiation for potentially resectable pancreactic cancer: A dose-finding study. (ASCO Annual Meeting Proceedings; post-meeting edition.) J Clin Oncol, 22(Suppl), pp. 4217.
54. Palmer, DH and Stocken, DD and Buckels, JAC and Hewitt, H and Markham, CE and Mirza, D and (2004) A randomised phase II trial of neoadjuvant chemotherapy for patients with resectable pancreatic cancer: Gemcitabine alone vs. gemcitabine combined with cisplatin. (ASCO Annual Meeting Proceedings; post-meeting edition.) J Clin Oncol, 22(Suppl), pp. 4215.
55. Doughlass, H. (1987) Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer Cancer, 59, pp. 2006-10.
56. Carducci, M and Abrams, R and Yeo, C and Hruban, RH and Zahurak, ML and Cameron, JL and (1996) Early evaluation of abdominal/hepatic irradiation and 5-fluorouracil infusion after pancreaticoduodenectomy Int J Radiat Oncol Biol Phys, 35, pp. 143-50.
57. Foo, M and Gunderson, L and Nagorney, D and McLlrath, DC and van Heerden, JA and Robinow, JS and (1993) Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation +/- 5-fluorouracil Int J Radiat Oncol Biol Phys, 26, pp. 483-9.
58. Foo, M and Gunderson, L. (1998) Adjuvant postoperative radiation therapy +/- 5-FU in resected carcinoma of the pancreas Hepatogastroenterology, 45(Pt 21), pp. 613-23.
59. Neoptolemos, J. (1998) Adjuvant radiotherapy and follow on chemotherapy in patients with pancreatic cancer: Results of the UK Pancreatic Cancer Study Group (UKPACA-1) GI Cancer, 2, pp. 235-45.
60. Kachnic, L and Shaw, J and Manning, M and Lauve, AD and Neifeld, JP. (2001) Gemcitabine following radiotherapy with concurrent 5-fluorouracil for nonmetastatic adenocarcinoma of the pancreas Int J Cancer, 96, pp. 132-9.
61. van Laethem, J and Demols, A and Gay, F and Closon, MT and Collette, M and Polus, M and (2003) Postoperative adjuvant gemcitabine and concurrent radiation after curative resection of pancreatic head carcinoma: A phase II study Int J Radiat Oncol Biol Phys, 56, pp. 974-80.
62. Allen, A and Zalupski, M and Robertson, J and Eckhauser, FE and Simone, D and Brown, D and (2004) Adjuvant therapy in pancreatic cancer: Phase I trial of radiation dose escalation with concurrent full-dose gemcitabine Int J Radiat Oncol Biol Phys, 59, pp. 1461-7.
63. Wilkowski, R and Thoma, M and Duhmke, E and Rau, HG and Heinemann, V. (2004) Concurrent chemoradiotherapy with gemcitabine and cisplatin after incomplete (R1) resection of locally advanced pancreatic carcinoma Int J Radiat Oncol Biol Phys, 58, pp. 768-72.